Response to Media Speculation & BCAL letter to GSS
Filed with ASX · · 3 pages · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- Quarterly Activities/Appendix 4C Cash Flow Report
- GSS Investor Presentation - Proposed Merger with MAP
- Receipt of Section 249D Notice from BCAL Diagnostics
- BDX Holdings of GSS Shares and receipt of Section 249D
- Genetic Signatures and Microba in Merger Discussions
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures